AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $471 | +26.6% | 6,741 | +30.1% | 0.00% | 0.0% |
| Q2 2023 | $372 | -49.9% | 5,183 | -46.1% | 0.00% | -50.0% |
| Q4 2022 | $742 | -99.8% | 9,624 | -5.6% | 0.00% | +100.0% |
| Q3 2022 | $455,000 | +1.8% | 10,200 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $447,000 | -16.8% | 11,673 | -10.1% | 0.00% | 0.0% |
| Q1 2022 | $537,000 | -16.2% | 12,991 | -23.5% | 0.00% | 0.0% |
| Q4 2021 | $641,000 | +30.5% | 16,984 | +13.9% | 0.00% | 0.0% |
| Q3 2021 | $491,000 | – | 14,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |